And please see below the Haig Barrett article that was recently published in the CPhI Show Daillies. Drug pricing remains pharma’s most contentious issue. Under tremendous pressure, the industry continues to evolve pricing strategy to satisfy intensive regulation, social/political scrutiny and competitive market forces — how other industries face the challenge of pricing may offer fresh insight to fuel an effective strategy. Getting pricing “right” is a tricky balancing act, but one that offers tremendous value for all.
